MERCK TO BUY GLYCOFI, ABMAXIS FOR $480M

Pharmaceutical company Merck & Co. Inc. said Tuesday it agreed to acquire GlycoFi Inc., a privately held biotechnology company, for $400 million in cash.

Business Week (http://www.businessweek.com/ap/financialnews/D8HG9N485.htm?campaign_id=apn_home_down&chan=db)